GlassScriptPhysician profile
Cole D Lundquist
NPI 1982688891
$68,689.20
in general payments reported to CMS, 2019-2025
16 companies · $4,750 in 2025
The $4,750 reported for 2025 was more than what 89% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57K · 2020: $6,440 · 2022: $66.32 · 2023: $155 · 2024: $610 · 2025: $4,750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,750 · Food and Beverage: $679 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,750.00 |
| Food and Beverage | $679.43 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $48,125.50 | 2019 | |
| Epi Health, LLC | $7,472.39 | 2019 | |
| Amgen INC. | $6,162.46 | 2020 | |
| Journey Medical Corporation | $5,362.25 | 2019-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $489.22 | 2019-2020 | |
| Dermavant Sciences, INC. | $459.07 | 2023-2024 | Vtama |
| Sun Pharmaceutical Industries INC. | $273.32 | 2019-2024 | Absorica Ld, Winlevi |
| Vyne Pharmaceuticals INC. | $77.69 | 2020 | |
| Pfizer INC. | $67.66 | 2019 | |
| Mayne Pharma Commercial LLC | $48.81 | 2019-2020 | |
| Abbvie INC. | $40.46 | 2023 | |
| Encore Dermatology INC. | $34.75 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $23.45 | 2024 | Dupixent |
| Arcutis Biotherapeutics, INC. | $19.24 | 2023 | |
| Novartis Pharmaceuticals Corporation | $17.85 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prugen, INC. Pharmaceuticals | $15.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cole Lundquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.